Cardiovascular Magnetic Resonance in Nonischemic Myocardial In fl ammation Expert Recommendations

This JACC Scienti fi c Expert Panel provides consensus recommendations for an update of the cardiovascular magnetic resonance (CMR) diagnostic criteria for myocardial in fl ammation in patients with suspected acute or active myocardial in fl ammation (Lake Louise Criteria) that include options to use parametric mapping techniques. While each parameter may indicate myocardial in fl ammation, the authors propose that CMR provides strong evidence for myocardial in fl ammation, with increasing speci fi city, if the CMR scan demonstrates the combination of myocardial edema with other CMR markers of in fl ammatory myocardial injury. This is based on at least one T2-based criterion (global or regional increase of myocardial T2 relaxation time or an increased signal intensity in T2-weighted CMR images), with at least one T1-based criterion (increased myocardial T1, extracellular volume, or late gadolinium enhancement). While having both a positive T2-based marker and a T1-based marker will increase speci fi city for diagnosing acute myocardial in fl ammation, having only one (i.e., T2-based OR T1-based) marker may still support a diagnosis of acute myocardial in fl ammation in an appropriate clinical scenario, albeit with less speci fi city. The update is expected to improve the diagnostic accuracy of CMR further in detecting myocardial in fl ammation. (J Am Coll Cardiol 2018;72:3158 – 76) © 2018 Published by Elsevier on behalf of the American College of Cardiology Foundation. The original Lake Louise Criteria I (left-most any out are supported by the largest but heterogeneous body of evidence. The evidence on other cardiac magnetic resonance (CMR) criteria combinations is also heterogeneous and much sparser. Nevertheless, the data suggest that novel mapping techniques may offer at least theoretical advantage over the original Lake Louise Criteria, pending further validation. The estimated area-under-the-curve (AUC*) is calculated as the average of the sensitivity and speci city reported for each in published studies. The bubbles tend to rise toward higher values of estimated area-under-the-curve for combinations that include mapping for at least study sample

[1]  C. Antoniades,et al.  Diagnostic Accuracy of Cardiovascular Magnetic Resonance in Acute Myocarditis: A Systematic Review and Meta-Analysis. , 2018, JACC. Cardiovascular imaging.

[2]  P. Lancellotti,et al.  [Update on myocarditis]. , 2018, Revue medicale de Liege.

[3]  R. Sullivan,et al.  Myocarditis in Patients Treated With Immune Checkpoint Inhibitors. , 2018, Journal of the American College of Cardiology.

[4]  Richard B. Thompson,et al.  Clinical recommendations for cardiovascular magnetic resonance mapping of T1, T2, T2* and extracellular volume: A consensus statement by the Society for Cardiovascular Magnetic Resonance (SCMR) endorsed by the European Association for Cardiovascular Imaging (EACVI) , 2017, Journal of Cardiovascular Magnetic Resonance.

[5]  M. Robson,et al.  CMR Native T1 Mapping Allows Differentiation of Reversible Versus Irreversible Myocardial Damage in ST-segment–Elevation Myocardial Infarction , 2017, Circulation. Cardiovascular imaging.

[6]  S. Raman,et al.  Global myocardial oedema in advanced decompensated heart failure , 2017, European heart journal cardiovascular Imaging.

[7]  Malte Kelm,et al.  Abnormal T2 mapping cardiovascular magnetic resonance correlates with adverse clinical outcome in patients with suspected acute myocarditis , 2017, Journal of Cardiovascular Magnetic Resonance.

[8]  C. Giannattasio,et al.  Quantitative changes in late gadolinium enhancement at cardiac magnetic resonance in the early phase of acute myocarditis. , 2017, International journal of cardiology.

[9]  P. Kellman,et al.  Detection and Monitoring of Acute Myocarditis Applying Quantitative Cardiovascular Magnetic Resonance , 2017, Circulation. Cardiovascular imaging.

[10]  D. Gur,et al.  Estimating the Area Under ROC Curve When the Fitted Binormal Curves Demonstrate Improper Shape. , 2017, Academic radiology.

[11]  Christopher A. Miller,et al.  Clinical applications of multi-parametric CMR in myocarditis and systemic inflammatory diseases , 2017, The International Journal of Cardiovascular Imaging.

[12]  P. Cluzel,et al.  Lupus Myocarditis: Initial Presentation and Longterm Outcomes in a Multicentric Series of 29 Patients , 2017, The Journal of Rheumatology.

[13]  B. Schnackenburg,et al.  T1 mapping cardiovascular magnetic resonance imaging to detect myocarditis-Impact of slice orientation on the diagnostic performance. , 2017, European journal of radiology.

[14]  P. Heusch,et al.  Feasibility of FDG-PET in myocarditis: Comparison to CMR using integrated PET/MRI , 2018, Journal of Nuclear Cardiology.

[15]  Andreas Greiser,et al.  Performance of native and contrast-enhanced T1 mapping to detect myocardial damage in patients with suspected myocarditis: a head-to-head comparison of different cardiovascular magnetic resonance techniques , 2017, The International Journal of Cardiovascular Imaging.

[16]  F. Gaita,et al.  Clinical and magnetic resonance evolution of “infarct-like” myocarditis , 2017, La radiologia medica.

[17]  C. Yancy,et al.  Current Diagnostic and Treatment Strategies for Specific Dilated Cardiomyopathies: A Scientific Statement From the American Heart Association. , 2016, Circulation.

[18]  U. Eriksson,et al.  The Quest for New Approaches in Myocarditis and Inflammatory Cardiomyopathy. , 2016, Journal of the American College of Cardiology.

[19]  B. Iung,et al.  Usefulness of Subepicardial Hyperemia on Contrast-Enhanced First-Pass Magnetic Resonance Perfusion Imaging for Diagnosis of Acute Myocarditis. , 2016, The American journal of cardiology.

[20]  R. Fimmers,et al.  Comprehensive Cardiac Magnetic Resonance for Short‐Term Follow‐Up in Acute Myocarditis , 2016, Journal of the American Heart Association.

[21]  S. Raman,et al.  Resolution of abnormal cardiac MRI T2 signal following immune suppression for cardiac sarcoidosis , 2016, Journal of Investigative Medicine.

[22]  P. Steg,et al.  Prognostic value of the infarct- and non-infarct like patterns and cardiovascular magnetic resonance parameters on long-term outcome of patients after acute myocarditis. , 2016, International journal of cardiology.

[23]  M. Robson,et al.  Pheochromocytoma Is Characterized by Catecholamine-Mediated Myocarditis, Focal and Diffuse Myocardial Fibrosis, and Myocardial Dysfunction. , 2016, Journal of the American College of Cardiology.

[24]  Matthias Gutberlet,et al.  Comprehensive Cardiac Magnetic Resonance Imaging in Patients With Suspected Myocarditis: The MyoRacer-Trial. , 2016, Journal of the American College of Cardiology.

[25]  M. Kupari,et al.  Cardiac magnetic resonance imaging reveals frequent myocardial involvement and dysfunction in active rheumatoid arthritis. , 2016, Clinical and experimental rheumatology.

[26]  J. Gieseke,et al.  Cardiac Magnetic Resonance Reveals Signs of Subclinical Myocardial Inflammation in Asymptomatic HIV-Infected Patients , 2016, Circulation. Cardiovascular imaging.

[27]  S. Piechnik,et al.  HIV-1–Related Cardiovascular Disease Is Associated With Chronic Inflammation, Frequent Pericardial Effusions, and Probable Myocardial Edema , 2016, Circulation. Cardiovascular imaging.

[28]  R. Fimmers,et al.  Incremental value of quantitative CMR including parametric mapping for the diagnosis of acute myocarditis. , 2016, European heart journal cardiovascular Imaging.

[29]  P. Kuchynka,et al.  Current Diagnostic and Therapeutic Aspects of Eosinophilic Myocarditis , 2016, BioMed research international.

[30]  R. Loose,et al.  Functional and Morphological Parameters with Tissue Characterization of Cardiovascular Magnetic Imaging in Clinically Verified “Infarct-like Myocarditis” , 2015, Fortschritte auf dem Gebiet der Röntgenstrahlen und der bildgebenden Verfahren.

[31]  B. Schnackenburg,et al.  T1 and T2 mapping cardiovascular magnetic resonance imaging techniques reveal unapparent myocardial injury in patients with myocarditis , 2016, Clinical Research in Cardiology.

[32]  C. Rochitte,et al.  Myocardial tissue characterization in Chagas’ heart disease by cardiovascular magnetic resonance , 2015, Journal of Cardiovascular Magnetic Resonance.

[33]  S. Maskatia,et al.  Cardiovascular magnetic resonance techniques and findings in children with myocarditis: a multicenter retrospective study , 2015, Journal of Cardiovascular Magnetic Resonance.

[34]  V. Fuster,et al.  Fast T2 gradient-spin-echo (T2-GraSE) mapping for myocardial edema quantification: first in vivo validation in a porcine model of ischemia/reperfusion , 2015, Journal of Cardiovascular Magnetic Resonance.

[35]  B. Schnackenburg,et al.  A systematic evaluation of three different cardiac T2-mapping sequences at 1.5 and 3T in healthy volunteers. , 2015, European journal of radiology.

[36]  D. Berman,et al.  Native T1 Mapping by 3-T CMR Imaging for Characterization of Chronic Myocardial Infarctions. , 2015, JACC. Cardiovascular imaging.

[37]  M. Friedrich,et al.  Importance of Reference Muscle Selection in Quantitative Signal Intensity Analysis of T2-Weighted Images of Myocardial Edema Using a T2 Ratio Method , 2015, BioMed research international.

[38]  P. Matthews,et al.  Diffuse Myocardial Fibrosis and Inflammation in Rheumatoid Arthritis: Insights From CMR T1 Mapping. , 2015, JACC. Cardiovascular imaging.

[39]  R. DeBiasi,et al.  Analysis of clinical parameters and cardiac magnetic resonance imaging as predictors of outcome in pediatric myocarditis. , 2015, The American journal of cardiology.

[40]  D. Kaye,et al.  Histological validation of cardiac magnetic resonance analysis of regional and diffuse interstitial myocardial fibrosis. , 2015, European heart journal cardiovascular Imaging.

[41]  M. Link,et al.  Eligibility and Disqualification Recommendations for Competitive Athletes With Cardiovascular Abnormalities: Task Force 3: Hypertrophic Cardiomyopathy, Arrhythmogenic Right Ventricular Cardiomyopathy and Other Cardiomyopathies, and Myocarditis: A Scientific Statement From the American Heart Associat , 2015, Journal of the American College of Cardiology.

[42]  M. Mayr,et al.  Native T1 in discrimination of acute and convalescent stages in patients with clinical diagnosis of myocarditis: a proposed diagnostic algorithm using CMR. , 2015, JACC. Cardiovascular imaging.

[43]  U. Sechtem,et al.  Diagnostic value of CMR in young patients with clinically suspected acute myocarditis is determined by cardiac enzymes , 2015, Clinical Research in Cardiology.

[44]  M. Friedrich,et al.  Predictive value of CMR criteria for LV functional improvement in patients with acute myocarditis. , 2014, European heart journal cardiovascular Imaging.

[45]  René M. Botnar,et al.  Coronary Vessel Wall Contrast Enhancement Imaging as a Potential Direct Marker of Coronary Involvement , 2014, JACC. Cardiovascular imaging.

[46]  H. Sakahara,et al.  Characteristics and clinical relevance of late gadolinium enhancement in cardiac magnetic resonance in patients with systemic sclerosis , 2014, Heart and Vessels.

[47]  B. Schnackenburg,et al.  CMR in patients with severe myocarditis: diagnostic value of quantitative tissue markers including extracellular volume imaging. , 2014, JACC. Cardiovascular imaging.

[48]  R. Fimmers,et al.  Acute myocarditis: multiparametric cardiac MR imaging. , 2014, Radiology.

[49]  G. Schuler,et al.  The potential additional diagnostic value of assessing for pericardial effusion on cardiac magnetic resonance imaging in patients with suspected myocarditis. , 2014, European heart journal cardiovascular Imaging.

[50]  M. Robson,et al.  Native T1-mapping detects the location, extent and patterns of acute myocarditis without the need for gadolinium contrast agents , 2014, Journal of Cardiovascular Magnetic Resonance.

[51]  M. Böhm,et al.  Diagnostic and prognostic validity of different biomarkers in patients with suspected myocarditis , 2014, Clinical Research in Cardiology.

[52]  L. Cooper,et al.  Cardiac magnetic resonance imaging in giant cell myocarditis: intriguing associations with clinical and pathological features. , 2014, Circulation.

[53]  P. Matthews,et al.  Subclinical myocardial inflammation and diffuse fibrosis are common in systemic sclerosis – a clinical study using myocardial T1-mapping and extracellular volume quantification , 2014, Journal of Cardiovascular Magnetic Resonance.

[54]  G. Wright,et al.  Correlation of late gadolinium enhancement MRI and quantitative T2 measurement in cardiac sarcoidosis , 2014, Journal of magnetic resonance imaging : JMRI.

[55]  C. Catalano,et al.  CMR sensitivity varies with clinical presentation and extent of cell necrosis in biopsy-proven acute myocarditis. , 2014, JACC. Cardiovascular imaging.

[56]  K. Klingel,et al.  Cardiovascular magnetic resonance risk stratification in patients with clinically suspected myocarditis , 2014, Journal of Cardiovascular Magnetic Resonance.

[57]  J. Schulz-Menger,et al.  Differentiation of acute and chronic myocardial infarction using T2-weighted imaging, late enhancement and T1 and T2 mapping - a pilot study at 3T , 2014, Journal of Cardiovascular Magnetic Resonance.

[58]  C. Canter,et al.  Diagnosis and treatment of myocarditis in children in the current era. , 2014, Circulation.

[59]  M. Robson,et al.  Myocardial T1 mapping and extracellular volume quantification: a Society for Cardiovascular Magnetic Resonance (SCMR) and CMR Working Group of the European Society of Cardiology consensus statement , 2013, Journal of Cardiovascular Magnetic Resonance.

[60]  Stefan Neubauer,et al.  T(1) mapping for the diagnosis of acute myocarditis using CMR: comparison to T2-weighted and late gadolinium enhanced imaging. , 2013, JACC. Cardiovascular imaging.

[61]  Tiina Heliö,et al.  Current state of knowledge on aetiology, diagnosis, management, and therapy of myocarditis: a position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases. , 2013, European heart journal.

[62]  Stefan Neubauer,et al.  T1 measurements in the human myocardium: The effects of magnetization transfer on the SASHA and MOLLI sequences , 2013, Magnetic resonance in medicine.

[63]  Scott D Flamm,et al.  Standardized image interpretation and post processing in cardiovascular magnetic resonance: Society for Cardiovascular Magnetic Resonance (SCMR) Board of Trustees Task Force on Standardized Post Processing , 2013, Journal of Cardiovascular Magnetic Resonance.

[64]  U. Kramer,et al.  CMR imaging predicts death and other adverse events in suspected cardiac sarcoidosis. , 2013, JACC. Cardiovascular imaging.

[65]  E. Nagel,et al.  Native Myocardial T1 Mapping by Cardiovascular Magnetic Resonance Imaging in Subclinical Cardiomyopathy in Patients With Systemic Lupus Erythematosus , 2013, Circulation. Cardiovascular imaging.

[66]  M. Friedrich,et al.  Assessment of acute myocarditis by cardiovascular MR: diagnostic performance of shortened protocols , 2013, The International Journal of Cardiovascular Imaging.

[67]  Matthias Stuber,et al.  Free-breathing 3 T magnetic resonance T2-mapping of the heart. , 2012, JACC. Cardiovascular imaging.

[68]  L. Cooper,et al.  Left ventricular assist device support and myocardial recovery in recent onset cardiomyopathy. , 2012, Journal of cardiac failure.

[69]  Peter Kellman,et al.  Extracellular volume fraction mapping in the myocardium, part 1: evaluation of an automated method , 2012, Journal of Cardiovascular Magnetic Resonance.

[70]  M. Spaeder,et al.  Demographics, Trends, and Outcomes in Pediatric Acute Myocarditis in the United States, 2006 to 2011 , 2012, Circulation. Cardiovascular quality and outcomes.

[71]  G. Kolovou,et al.  Hyperthyroidism induced autoimmune myocarditis. Evaluation by cardiovascular magnetic resonance and endomyocardial biopsy. , 2012, International journal of cardiology.

[72]  M. Robson,et al.  Non-contrast T1-mapping detects acute myocardial edema with high diagnostic accuracy: a comparison to T2-weighted cardiovascular magnetic resonance , 2012, Journal of Cardiovascular Magnetic Resonance.

[73]  G. Schuler,et al.  Diagnostic performance of CMR imaging compared with EMB in patients with suspected myocarditis. , 2012, JACC. Cardiovascular imaging.

[74]  Titus Kuehne,et al.  Cardiovascular magnetic resonance of myocardial edema using a short inversion time inversion recovery (STIR) black-blood technique: Diagnostic accuracy of visual and semi-quantitative assessment , 2012, Journal of Cardiovascular Magnetic Resonance.

[75]  Paaladinesh Thavendiranathan,et al.  Improved Detection of Myocardial Involvement in Acute Inflammatory Cardiomyopathies Using T2 Mapping , 2012, Circulation. Cardiovascular imaging.

[76]  R. Biederman,et al.  Cardiac Sarcoidosis or Giant Cell Myocarditis? On Treatment Improvement of Fulminant Myocarditis as Demonstrated by Cardiovascular Magnetic Resonance Imaging , 2011, Case reports in cardiology.

[77]  M. Olschewski,et al.  Diagnosis of viral myocarditis by cardiac magnetic resonance and viral genome detection in peripheral blood , 2012, The International Journal of Cardiovascular Imaging.

[78]  Jain Mangalathu Arumana,et al.  CMR imaging of edema in myocardial infarction using cine balanced steady-state free precession. , 2011, JACC. Cardiovascular imaging.

[79]  Amit R. Patel,et al.  Myocardial damage in patients with sarcoidosis and preserved left ventricular systolic function: an observational study , 2011, European journal of heart failure.

[80]  G. Schuler,et al.  Clinical characteristics and cardiovascular magnetic resonance findings in stress (takotsubo) cardiomyopathy. , 2011, JAMA.

[81]  M. Böhm,et al.  Prognostic electrocardiographic parameters in patients with suspected myocarditis , 2011, European journal of heart failure.

[82]  M. Böhm,et al.  Virus serology in patients with suspected myocarditis: utility or futility? , 2011, European heart journal.

[83]  O. Simonetti,et al.  Direct T2 quantification of myocardial edema in acute ischemic injury. , 2011, JACC. Cardiovascular imaging.

[84]  M. Schieber,et al.  Comparative Evaluation of Left and Right Ventricular Endomyocardial Biopsy: Differences in Complication Rate and Diagnostic Performance , 2010, Circulation.

[85]  M. Cheitlin Diagnostic synergy of non-invasive cardiovascular magnetic resonance and invasive endomyocardial biopsy in troponin-positive patients without coronary artery disease , 2010 .

[86]  R. Kim,et al.  Detection of Myocardial Damage in Patients With Sarcoidosis , 2009, Circulation.

[87]  K. Klingel,et al.  Imaging in inflammatory heart disease: from the past to current clinical practice. , 2009, Hellenic journal of cardiology : HJC = Hellenike kardiologike epitheorese.

[88]  M. Friedrich,et al.  Age and gender effects on the extent of myocardial involvement in acute myocarditis: a cardiovascular magnetic resonance study , 2009, Heart.

[89]  P. Bruneval,et al.  Different focal delayed gadolinium-enhancement patterns using cardiac magnetic resonance in a case of diffuse giant cell myocarditis. , 2009, European heart journal.

[90]  J. Bogaert,et al.  Cardiovascular magnetic resonance in pericardial diseases , 2009, Journal of cardiovascular magnetic resonance : official journal of the Society for Cardiovascular Magnetic Resonance.

[91]  Matthias Gutberlet,et al.  Cardiovascular Magnetic Resonance in Myocarditis: A JACC White Paper , 2009 .

[92]  Michael Böhm,et al.  Predictors of Outcome in Patients With Suspected Myocarditis , 2008, Circulation.

[93]  R. Wassmuth,et al.  Myocardial tissue characterization in systemic lupus erythematosus: value of a comprehensive cardiovascular magnetic resonance approach , 2008, Lupus.

[94]  M. Gutberlet,et al.  Suspected chronic myocarditis at cardiac MR: diagnostic accuracy and association with immunohistologically detected inflammation and viral persistence. , 2008, Radiology.

[95]  Peter Kellman,et al.  ACUT2E TSE‐SSFP: A hybrid method for T2‐weighted imaging of edema in the heart , 2008, Magnetic resonance in medicine.

[96]  Renu Virmani,et al.  A Scientific Statement from the American Heart Association, the American College of Cardiology, and the European Society of Cardiology , 2022 .

[97]  E. McVeigh,et al.  T2‐prepared SSFP improves diagnostic confidence in edema imaging in acute myocardial infarction compared to turbo spin echo , 2007, Magnetic resonance in medicine.

[98]  C. Gaudio,et al.  Delayed gadolinium-enhanced cardiac magnetic resonance in patients with chronic myocarditis presenting with heart failure or recurrent arrhythmias. , 2006, Journal of the American College of Cardiology.

[99]  D. Bluemke,et al.  Giant cell myocarditis depicted by cardiac magnetic resonance imaging. , 2005, Journal of computer assisted tomography.

[100]  J. Lima,et al.  Myocardial delayed enhancement by magnetic resonance imaging in patients with Chagas' disease: a marker of disease severity. , 2005, Journal of the American College of Cardiology.

[101]  Fabien Hyafil,et al.  Differentiating acute myocardial infarction from myocarditis: diagnostic value of early- and delayed-perfusion cardiac MR imaging. , 2005, Radiology.

[102]  J. Schulz-Menger,et al.  Diagnostic performance of cardiovascular magnetic resonance in patients with suspected acute myocarditis: comparison of different approaches. , 2005, Journal of the American College of Cardiology.

[103]  Nancy A Obuchowski,et al.  Clinical evaluation of diagnostic tests. , 2005, AJR. American journal of roentgenology.

[104]  C. Marzban The ROC Curve and the Area under It as Performance Measures , 2004 .

[105]  R. Hruban,et al.  Endomyocardial biopsy plays a role in diagnosing patients with unexplained cardiomyopathy. , 2004, American heart journal.

[106]  B. Iung,et al.  MRI of acute myocarditis: a comprehensive approach based on various imaging sequences. , 2002, Chest.

[107]  L. Cooper,et al.  Giant Cell Myocarditis: Diagnosis and Treatment , 2000, Herz.

[108]  O. Simonetti,et al.  "Black blood" T2-weighted inversion-recovery MR imaging of the heart. , 1996, Radiology.